InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Taysha Gene Therapies, Inc.

TSHA Clue Score55
United States Fiscal year ends December CIK 0001806310 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

66
Insider
Date
Role
Action
Shares
Price
Amount
Sukumar Nagendran
10 Jul 2026
President and Head of R&D
Sold on a plan
200,000
$6.24
$1.25M
Sukumar Nagendran
10 Apr 2026
President and Head of R&D
Sold after exercise
200,000
$4.46
$892.00K
Kamran Alam
4 Feb 2026
Chief Financial Officer
Sell
1,655
$4.52
$7.48K
Kamran Alam
26 Jan 2026
Chief Financial Officer
Sell
23,849
$4.61
$109.94K
Sean P. Nolan
26 Jan 2026
Chief Executive Officer
Sell
41,312
$4.61
$190.45K
Sukumar Nagendran
26 Jan 2026
President and Head of R&D
Sell
26,918
$4.61
$124.09K
Kamran Alam
23 Jan 2026
Chief Financial Officer
Sell
78,968
$4.75
$375.10K
Sean P. Nolan
23 Jan 2026
Chief Executive Officer
Sell
136,789
$4.75
$649.75K
Sukumar Nagendran
23 Jan 2026
President and Head of R&D
Sell
89,132
$4.75
$423.38K
Sukumar Nagendran
12 Jan 2026
President and Head of R&D
Sold after exercise
200,000
$4.71
$942.00K
Sukumar Nagendran
1 Dec 2025
President and Head of R&D
Sold after exercise
260,047
$4.51
$1.17M
Sukumar Nagendran
28 Nov 2025
President and Head of R&D
Sold after exercise
110,125
$4.75
$523.09K
Sukumar Nagendran
10 Sep 2025
President and Head of R&D
Sold after exercise
200,000
$3.23
$646.00K
Kamran Alam
21 Aug 2025
Chief Financial Officer
Sell
54,491
$2.85
$155.30K
Sukumar Nagendran
21 Aug 2025
President and Head of R&D
Sell
57,054
$2.85
$162.60K
Paul B Manning
30 May 2025
10% owner
Buy indirect
750,000
$2.75
$2.06M
Paul B Manning
27 Jun 2024
10% owner
Buy
1,333,333
$2.25
$3.00M
Paul B Manning
17 Nov 2023
10% owner
Buy indirect
100,000
$1.63
$163.00K
Kamran Alam
24 Aug 2023
Chief Financial Officer
Sold on a plan
33,000
$2.33
$76.89K
Phillip B. Donenberg
16 Aug 2023
Director
Buy
111,111
$0.90
$100.00K
Sean P. Nolan
16 Aug 2023
Chief Executive Officer
Buy indirect
444,444
$0.90
$400.00K
John A Stalfort III
16 Aug 2023
Director
Buy
388,889
$0.90
$350.00K
John A Stalfort III
16 Aug 2023
Director
Buy indirect
388,889
$0.90
$350.00K
Paul B Manning
16 Aug 2023
10% owner
Buy indirect
16,466,667
$0.90
$14.82M
R.A. Session II
13 Jul 2023
10% owner
Sell
5,344
$0.70
$3.74K
R.A. Session II
12 Jul 2023
10% owner
Sell
80,528
$0.71
$57.03K
R.A. Session II
23 Jun 2023
10% owner
Sell
18,100
$0.70
$12.74K
R.A. Session II
22 Jun 2023
10% owner
Sell
10,508
$0.70
$7.38K
R.A. Session II
21 Jun 2023
10% owner
Sell
138,962
$0.70
$97.63K
R.A. Session II
20 Jun 2023
10% owner
Sell
295,653
$0.71
$210.21K
Sukumar Nagendran
16 May 2023
President and Head of R&D
Buy
5,000
$0.68
$3.40K
Paul B Manning
31 Oct 2022
Director
Buy
1,500,000
$2.00
$3.00M
Kamran Alam
23 Aug 2022
Chief Financial Officer
Sell
3,325
$3.47
$11.54K
Kamran Alam
22 Aug 2022
Chief Financial Officer
Sell
9,717
$3.50
$34.01K
Kamran Alam
19 Aug 2022
Chief Financial Officer
Sell
11,482
$3.75
$43.06K
Kamran Alam
18 Aug 2022
Chief Financial Officer
Sell
7,476
$3.87
$28.93K
Suyash Prasad
6 Jul 2022
CMO and Head of R&D
Sell
8,956
$3.79
$33.94K
Suyash Prasad
5 Jul 2022
CMO and Head of R&D
Sell
3,905
$3.51
$13.71K
Suyash Prasad
1 Jul 2022
CMO and Head of R&D
Sell
23,923
$3.53
$84.45K
Suyash Prasad
30 Jun 2022
CMO and Head of R&D
Sell
13,892
$3.72
$51.68K
Suyash Prasad
29 Jun 2022
CMO and Head of R&D
Sell
12,324
$3.81
$46.95K
Paul B Manning
3 Feb 2022
Director
Buy indirect
26,602
$7.84
$208.56K
Paul B Manning
3 Feb 2022
Director
Buy
50,000
$7.84
$392.00K
Phillip B. Donenberg
2 Feb 2022
Director
Buy
3,000
$7.78
$23.34K
Sukumar Nagendran
2 Feb 2022
Director
Buy
10,000
$8.01
$80.10K
Paul B Manning
2 Feb 2022
Director
Buy indirect
22,000
$7.77
$170.94K
Paul B Manning
2 Feb 2022
Director
Buy indirect
45,000
$7.77
$349.65K
Paul B Manning
2 Feb 2022
Director
Buy
58,000
$7.77
$450.66K
Paul B Manning
24 Nov 2021
Director
Buy
2,202
$13.19
$29.04K
Paul B Manning
23 Nov 2021
Director
Buy
20,000
$12.54
$250.80K
R.A. Session II
23 Nov 2021
President and CEO
Buy
26,008
$12.65
$329.00K
R.A. Session II
23 Nov 2021
President and CEO
Buy
16,510
$12.12
$200.10K
Kamran Alam
20 Aug 2021
Chief Financial Officer
Sell
2,094
$17.14
$35.89K
Kamran Alam
20 Aug 2021
Chief Financial Officer
Sell
9,746
$16.70
$162.76K
Kamran Alam
19 Aug 2021
Chief Financial Officer
Sell
613
$17.11
$10.49K
Kamran Alam
19 Aug 2021
Chief Financial Officer
Sell
9,354
$16.43
$153.69K
Kamran Alam
18 Aug 2021
Chief Financial Officer
Sell
11,193
$17.35
$194.20K
Suyash Prasad
1 Jul 2021
CMO and Head of R&D
Sell
19,706
$21.12
$416.19K
Suyash Prasad
30 Jun 2021
CMO and Head of R&D
Sell
500
$23.70
$11.85K
Suyash Prasad
30 Jun 2021
CMO and Head of R&D
Sell
6,202
$22.44
$139.17K
Suyash Prasad
30 Jun 2021
CMO and Head of R&D
Sell
13,374
$21.42
$286.47K
Suyash Prasad
29 Jun 2021
CMO and Head of R&D
Sell
300
$25.19
$7.56K
Suyash Prasad
29 Jun 2021
CMO and Head of R&D
Sell
3,862
$24.46
$94.46K
Suyash Prasad
29 Jun 2021
CMO and Head of R&D
Sell
35,056
$23.74
$832.23K
Sean P. Nolan
20 May 2021
Director
Buy
1,170
$22.35
$26.15K
Paul B Manning
14 May 2021
Director
Buy
12,000
$20.98
$251.76K

What was left out

Form 4 filings counted 106
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 5
Sales at will 36
Transactions with no price 0
Shares from compensation/vesting 14,986,465
Sales filed before the plan box existed 21
History held since 25 Sep 2020